|
|
|
|
Science Sparks @ ACTREC
|
 26thMay 2025 |
Vol. No. 14 ; Issue No.684 |
|
|
Publications
|
|
1. Hasan SK, Jayakumar S, Espina Barroso E, Jha A, Catalano G, Sandur SK, Noguera NI (2025). Molecular targets of oxidative stress: Focus on nuclear factor erythroid 2–related factor 2 function in leukemia and other cancers. Cells. 14(10):713.
2. Joshi P, Bane S, Chaturvedi P, Gera P, Waghmare SK (2025). Establishment and characterization of patient-derived tongue squamous cell carcinoma cell lines. Human Cell. 38(4):102.
3. Anthony C, Harish M, Christie J, Venkatraman P (2025). Novel interaction with PSMD9 regulates DNAJA1 turnover and mitochondrial polarity. Biochemical and Biophysical Research Communications.
4. Dasgupta A, Mani S, Chatterjee A, Kannan S, Moiyadi A, Shetty P, Singh V, Menon N, Sahu A, Choudhary A, Bhattacharya K, Puranik A, Dev I, Epari S, Sahay A, Shah A, Bano N, Shaikh F, Gupta T (2025). Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial. BMC Cancer. 25(1):911.
5. Murthy V, Samanta A, Maitre P, Nayak P, Singh P, Agrawal A, Joshi A, Prakash G (2025). Abiraterone for "STAMPEDE-Like" cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early? Prostate Cancer and Prostatic Diseases.
6. Mirgh S, Yanamandra U, Vishvanathan G, Gundeti S, Khattry N, John M, Malhotra P, Menon H, Das B, Nair R, Nair V, Saikia T, Kumar S (2025). Clinical perspectives on amyloidosis in India: A systematic literature review. Clinical Lymphoma Myeloma and Leukemia.
7. Ghosh -Laskar S, Sood S, Chatterjeec A, Sinha S, Sharma S, Chaukar D, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Swain M, Kumar A, Mohanty S, Chaturvedi P, Pai P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Tuljapurkar V, Deshpande M, Joshi A, Noronha V, Prabhash K, D'cruz A. (2025) Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843). Radiotherapy and Oncology.
|
|
|
|
|
Interesting Reads
|
|
Jiang M, Zhang K, Wei G, Qi F, Yu D, Ma J, Zhang X, Chen L, Xie Y, Yu Z, Chen J, Chen D (2025). HDAC4 super-enhancer drives CEBPB-mediated TWIST2 transcription to promote chemoresistance in LUAD. Cancer Letters.
|
|
|
Video of the Week
|
.png)
|
| Genomic Insights into Colon Cancer Research |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1945, Felix Bloch and Edward Purcell discovered nuclear magnetic resonance which is used to detect brain tumors and other cancers.
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
